Accuray Inc
NASDAQ:ARAY
Accuray Inc
Research & Development
Accuray Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Accuray Inc
NASDAQ:ARAY
|
Research & Development
-$44.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Research & Development
-$1.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$2.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-21%
|
|
Accuray Inc
Glance View
Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
See Also
What is Accuray Inc's Research & Development?
Research & Development
-44.1m
USD
Based on the financial report for Dec 31, 2025, Accuray Inc's Research & Development amounts to -44.1m USD.
What is Accuray Inc's Research & Development growth rate?
Research & Development CAGR 10Y
3%
Over the last year, the Research & Development growth was 5%. The average annual Research & Development growth rates for Accuray Inc have been 8% over the past three years , 1% over the past five years , and 3% over the past ten years .
